Search Results - "Sahra, I. Ben"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level by Sahra, I Ben, Laurent, K, Loubat, A, Giorgetti-Peraldi, S, Colosetti, P, Auberger, P, Tanti, J F, Le Marchand-Brustel, Y, Bost, F

    Published in Oncogene (05-06-2008)
    “…Metformin is a widely used antidiabetic agent, which regulates glucose homeostasis through inhibition of liver glucose production and an increase in muscle…”
    Get full text
    Journal Article
  2. 2

    Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP by Ricoult, S J H, Yecies, J L, Ben-Sahra, I, Manning, B D

    Published in Oncogene (10-03-2016)
    “…An enhanced capacity for de novo lipid synthesis is a metabolic feature of most cancer cells that distinguishes them from their cells of origin. However, the…”
    Get full text
    Journal Article
  3. 3

    Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death by Ben-Sahra, I, Dirat, B, Laurent, K, Puissant, A, Auberger, P, Budanov, A, Tanti, J-F, Bost, F

    Published in Cell death and differentiation (01-04-2013)
    “…The phosphoinositide-3 kinase/Akt (PI3K/Akt) pathway has a central role in cancer cell metabolism and proliferation. More importantly, it is one of the…”
    Get full text
    Journal Article
  4. 4

    The mitochondrial NADH shuttle system is a targetable vulnerability for Group 3 medulloblastoma in a hypoxic microenvironment by Contenti, J., Guo, Y., Mazzu, A., Irondelle, M., Rouleau, M., Lago, C., Leva, G., Tiberi, L., Ben-Sahra, I., Bost, F., Mazure, N. M.

    Published in Cell death & disease (30-11-2023)
    “…Medulloblastoma is a cancerous brain tumor that affects mostly children. Among the four groups defined by molecular characteristics, Group 3, the least well…”
    Get full text
    Journal Article
  5. 5

    Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response by Lall, R, Ganapathy, S, Yang, M, Xiao, S, Xu, T, Su, H, Shadfan, M, Asara, J M, Ha, C S, Ben-Sahra, I, Manning, B D, Little, J B, Yuan, Z-M

    Published in Cell death and differentiation (01-05-2014)
    “…Because of insufficient understanding of the molecular effects of low levels of radiation exposure, there is a great uncertainty regarding its health risks. We…”
    Get full text
    Journal Article
  6. 6

    HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma by Contenti, J., Guo, Y., Larcher, M., Mirabal-Ortega, L., Rouleau, M., Irondelle, M., Tiroille, V., Mazzu, A., Duranton-Tanneur, V., Pedeutour, F., Ben-Sahra, I., Lago, C., Leva, G., Tiberi, L., Robert, G., Pouponnot, C., Bost, F., Mazure, N. M.

    Published in Cell death discovery (24-07-2024)
    “…Medulloblastoma (MB) is the most prevalent brain cancer in children. Four subgroups of MB have been identified; of these, Group 3 is the most metastatic. Its…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The mitochondrial NADH shuttle system is a targetable vulnerability for Group 3 medulloblastoma in a hypoxic microenvironment by Contenti, J., Guo, Y, Mazzu, A, Irondelle, M, Rouleau, M, Lago, C, Leva, G, Tiberi, L, Ben-Sahra, I., Bost, Frédéric, Mazure, N M

    Published in Cell death & disease (2023)
    “…Medulloblastoma is a cancerous brain tumor that affects mostly children. Among the four groups defined by molecular characteristics, Group 3, the least well…”
    Get full text
    Journal Article
  9. 9

    O49 L’hypoxie inhibe la voie de signalisation de l’insuline dans les adipocytes by Regazzetti, C, Peraldi, P, Ben-Sahra, I, Cormont, M, Bost, F, Le Marchand-Brustel, Y, Tanti, J.F, Giorgetti-Peraldi, S

    Published in Diabetes & metabolism (2009)
    “…Introduction L’obésité se caractérise par une croissance excessive du tissu adipeux qui pourrait être à l’origine de la formation de zones hypoxiques. Nous…”
    Get full text
    Journal Article
  10. 10

    OS6.1 Targeting Purine Metabolism to Overcome Therapeutic Resistance in Glioblastoma by Ahmed, A U, Shireman, J, Atashi, F, Saathoff, M, Ali, E, Lee, G, Park, C, Savchuk, S, Rayyan, J, James, C, Ben-Sahra, I

    Published in Neuro-oncology (Charlottesville, Va.) (06-09-2019)
    “…Abstract BACKGROUND A distinguishing characteristic of all cancers is uncontrolled cell division, and they require additional nucleotide bases such as purines,…”
    Get full text
    Journal Article
  11. 11
  12. 12

    O45 La metformine exerce un effet anti-tumoral et entraîne un arrêt du cycle cellulaire by Ben Sahra, I, Laurent, K, Loubat, A, Peraldi, S.G, Colosetti, P, Auberger, P, Tanti, J.F, Le Marchand-Brustel, Y, Bost, F

    Published in Diabetes & metabolism (2008)
    “…Introduction La metformine est un médicament couramment prescrit contre le diabète de type II, qui inhibe la production hépatique de glucose et augmente la…”
    Get full text
    Journal Article
  13. 13

    HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma by Contenti, J., Guo, Y., Larcher, M., Mirabal-Ortega, L., Rouleau, M., Irondelle, M., Tiroille, V., Mazzu, A., Duranton-Tanneur, V., Pedeutour, F., Ben-Sahra, I., Lago, C., Leva, G., Tiberi, L., Robert, G., Pouponnot, C., Bost, F., Mazure, Nathalie M

    Published in Cell death discovery (24-07-2024)
    “…Abstract Medulloblastoma (MB) is the most prevalent brain cancer in children. Four subgroups of MB have been identified; of these, Group 3 is the most…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Obésité et cancers du côlon et de la prostate: implication des adipokines by Ben Sahra, I., Le Marchand Brustel, Y., Tanti, J. -F., Bost, F.

    Published in Obésite (01-06-2008)
    “…Résumé L’obésité est associée à de nombreuses pathologies comme le diabète et les maladies cardiovasculaires. Plus récemment, il a été montré que l’incidence…”
    Get full text
    Journal Article
  20. 20